Hovione, IDC Launch Intranasal Drug Delivery Platform
Contract Pharma, 7 May 2026
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Contract Pharma, 7 May 2026
Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform.
Drug Delivery Technology, April 2010
‘One Site Shop’ expands to respond to growing demands
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey facility in East Windsor, USA
Hovione is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.
Silicon Republic, October 2, 2020
Its lead single-use nasal dry powder device now available for commercial partnerships